A Randomized, Multicenter Study of the Safety and Performance of Fabian PRICO for Saturation Targeting With Non-invasive Respiratory Support

Respiratory Insufficiency Syndrome of Newborn Clinical Trial

Official title: A Randomized, Multicenter Study of the Safety and Performance of Fabian PRICO for Saturation Targeting With Non-invasive Respiratory Support

Status Not yet recruiting

Clinical Trial Summary

This study is planned as a part of the post market clinical follow-up (PMCF) on a CE marked product. The purpose of this study is to assess, in a routine clinical environment at two centers the use of fabian-PRICO with noninvasive ventilation and its safety and performance at targeting and maintaining accurate SpO2 levels.

Clinical Trial Description

This is a randomized cross-over study. Subjects will be assigned to two, nominally 12-hour interventions, one with standard manual titration of FiO2 and the other with automated adjustment (PRICO). The order of these two interventions will be random.

In addition to the ventilators data, basic demographics (i.e., gestational age, birth weight, age, weight at study) of the participating infants will be recorded in the eCRF.

This study has no additional follow-up visits. ;

Related Conditions & MeSH terms

• Respiratory Insufficiency
• Respiratory Insufficiency Syndrome of Newborn

• NCT number: NCT05823909
• Study type: Observational
• Source: Vyaire Medical
• Contact: Jens Krugmann, MD
• Phone: +41 76 5090989
• Email: Jens.Krugmann@vyaire.com
• Status: Not yet recruiting
• Start date: June 2023
• Completion date: August 2024